Ingevity reports third quarter 2026 financial results
Ingevity reported Q3 2026 net sales of $305.1 million, down 8% year-over-year due to the April 2026 Road Markings divestiture, though sales grew 2% excluding that divestiture. Net income from continuing operations was $51.1 million ($1.46 diluted EPS) and adjusted EPS rose 24% to $1.63 from $1.31, while adjusted EBITDA margin expanded 230 bps to 35.4%. Management narrowed full-year adjusted EBITDA guidance to $385-395 million, maintaining the prior midpoint, and guided diluted adjusted EPS of $5.25-$5.45 with free cash flow of $220-230 million.
Key figures
- Eps
- 1.46
- Revenue
- 305.1
- Guidance
- FY26 adjusted EBITDA narrowed to $385M-$395M (midpoint maintained); net sales ~$1.1B; diluted adjusted EPS $5.25-$5.45; FCF $220M-$230M excluding $113.2M litigation settlement payment
- Revenue Yoy
- -8%
- Fcf
- 85500000
- Q3 buybacks
- $39 million at weighted average $71.45/share
- Adjusted eps
- 1.63
- Net leverage
- 2.5x
- Ytd buybacks
- $125 million
- Adjusted ebitda
- 108000000
- Operating cash flow
- 99200000
- Adjusted ebitda margin
- 35.4%
- Adjusted eps prior year
- 1.31
- Buyback capacity remaining
- $172 million
- Adjusted ebitda margin change
- +230 bps
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.